Commonwealth Equity Services’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
RCM
ACA
JT
Commonwealth Equity Services's ASND Position: Q2 2026 in Review
Commonwealth Equity Services increased its Ascendis Pharma A/S (ASND) stake by 3.1% in Q2 2026, buying an estimated $8.64K and bringing the position to 1,222 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #3699.
Commonwealth Equity Services first reported a position in ASND in Q4 2025 and has held it in 3 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.
- Commonwealth Equity Services held 1,222 shares of Ascendis Pharma A/S worth $326K as of Q2 2026.
- Commonwealth Equity Services bought 37 Ascendis Pharma A/S shares in Q2 2026, an estimated $8.64K.
- Ascendis Pharma A/S made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3699 holding.
- Commonwealth Equity Services first reported a position in Ascendis Pharma A/S in Q4 2025 and has held it in 3 quarters since.
- 312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.